vs
Side-by-side financial comparison of AbCellera Biologics Inc. (ABCL) and Postal Realty Trust, Inc. (PSTL). Click either name above to swap in a different company.
AbCellera Biologics Inc. is the larger business by last-quarter revenue ($44.9M vs $26.0M, roughly 1.7× Postal Realty Trust, Inc.). Postal Realty Trust, Inc. runs the higher net margin — 17.9% vs -19.9%, a 37.8% gap on every dollar of revenue. On growth, AbCellera Biologics Inc. posted the faster year-over-year revenue change (788.4% vs 21.7%). Postal Realty Trust, Inc. produced more free cash flow last quarter ($37.6M vs $-44.6M). Over the past eight quarters, AbCellera Biologics Inc.'s revenue compounded faster (112.3% CAGR vs 22.6%).
AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.
Postal Realty Trust, Inc. is a specialized real estate investment trust that acquires, owns, and manages properties primarily leased to the United States Postal Service. Its portfolio includes last-mile postal facilities, sorting centers, and retail post office locations across the U.S., supporting critical mail and package delivery infrastructure.
ABCL vs PSTL — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | ||
|---|---|---|
| Revenue | $44.9M | $26.0M |
| Net Profit | $-8.9M | $4.6M |
| Gross Margin | — | — |
| Operating Margin | -63.7% | 39.2% |
| Net Margin | -19.9% | 17.9% |
| Revenue YoY | 788.4% | 21.7% |
| Net Profit YoY | 73.9% | 3.1% |
| EPS (diluted) | $-0.03 | $0.16 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $44.9M | $26.0M | ||
| Q3 25 | $9.0M | $24.3M | ||
| Q2 25 | $17.1M | $23.4M | ||
| Q1 25 | $4.2M | $22.1M | ||
| Q4 24 | $5.0M | $21.4M | ||
| Q3 24 | $6.5M | $19.7M | ||
| Q2 24 | $7.3M | $18.1M | ||
| Q1 24 | $10.0M | $17.3M |
| Q4 25 | $-8.9M | $4.6M | ||
| Q3 25 | $-57.1M | $3.8M | ||
| Q2 25 | $-34.7M | $3.6M | ||
| Q1 25 | $-45.6M | $2.1M | ||
| Q4 24 | — | $4.5M | ||
| Q3 24 | $-51.1M | $1.1M | ||
| Q2 24 | $-36.9M | $817.0K | ||
| Q1 24 | $-40.6M | $206.0K |
| Q4 25 | -63.7% | 39.2% | ||
| Q3 25 | -851.8% | 37.6% | ||
| Q2 25 | -290.2% | 37.3% | ||
| Q1 25 | -1479.6% | 28.4% | ||
| Q4 24 | — | 43.2% | ||
| Q3 24 | -1439.4% | 24.3% | ||
| Q2 24 | -1276.2% | 22.8% | ||
| Q1 24 | -551.5% | 17.6% |
| Q4 25 | -19.9% | 17.9% | ||
| Q3 25 | -637.8% | 15.7% | ||
| Q2 25 | -203.3% | 15.5% | ||
| Q1 25 | -1077.2% | 9.4% | ||
| Q4 24 | — | 21.1% | ||
| Q3 24 | -785.4% | 5.4% | ||
| Q2 24 | -504.3% | 4.5% | ||
| Q1 24 | -408.0% | 1.2% |
| Q4 25 | $-0.03 | $0.16 | ||
| Q3 25 | $-0.19 | $0.13 | ||
| Q2 25 | $-0.12 | $0.12 | ||
| Q1 25 | $-0.15 | $0.06 | ||
| Q4 24 | — | $0.17 | ||
| Q3 24 | $-0.17 | $0.03 | ||
| Q2 24 | $-0.13 | $0.02 | ||
| Q1 24 | $-0.14 | $-0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $128.5M | $1.5M |
| Total DebtLower is stronger | — | $361.1M |
| Stockholders' EquityBook value | $966.9M | $285.2M |
| Total Assets | $1.4B | $759.1M |
| Debt / EquityLower = less leverage | — | 1.27× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $128.5M | $1.5M | ||
| Q3 25 | $83.2M | $1.9M | ||
| Q2 25 | $92.4M | $1.1M | ||
| Q1 25 | $159.3M | $639.0K | ||
| Q4 24 | $156.3M | $1.8M | ||
| Q3 24 | $126.6M | $970.0K | ||
| Q2 24 | $148.3M | $1.7M | ||
| Q1 24 | $123.6M | $1.9M |
| Q4 25 | — | $361.1M | ||
| Q3 25 | — | $347.0M | ||
| Q2 25 | — | $328.8M | ||
| Q1 25 | — | $306.7M | ||
| Q4 24 | — | $296.7M | ||
| Q3 24 | — | $277.0M | ||
| Q2 24 | — | $273.7M | ||
| Q1 24 | — | $247.6M |
| Q4 25 | $966.9M | $285.2M | ||
| Q3 25 | $964.0M | $273.9M | ||
| Q2 25 | $1.0B | $250.8M | ||
| Q1 25 | $1.0B | $245.5M | ||
| Q4 24 | $1.1B | $251.3M | ||
| Q3 24 | $1.1B | $245.6M | ||
| Q2 24 | $1.1B | $245.5M | ||
| Q1 24 | $1.1B | $248.1M |
| Q4 25 | $1.4B | $759.1M | ||
| Q3 25 | $1.4B | $735.2M | ||
| Q2 25 | $1.4B | $689.8M | ||
| Q1 25 | $1.3B | $654.0M | ||
| Q4 24 | $1.4B | $646.8M | ||
| Q3 24 | $1.4B | $615.1M | ||
| Q2 24 | $1.4B | $608.2M | ||
| Q1 24 | $1.5B | $584.1M |
| Q4 25 | — | 1.27× | ||
| Q3 25 | — | 1.27× | ||
| Q2 25 | — | 1.31× | ||
| Q1 25 | — | 1.25× | ||
| Q4 24 | — | 1.18× | ||
| Q3 24 | — | 1.13× | ||
| Q2 24 | — | 1.11× | ||
| Q1 24 | — | 1.00× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $-34.7M | $44.5M |
| Free Cash FlowOCF − Capex | $-44.6M | $37.6M |
| FCF MarginFCF / Revenue | -99.4% | 144.5% |
| Capex IntensityCapex / Revenue | 21.9% | 26.7% |
| Cash ConversionOCF / Net Profit | — | 9.59× |
| TTM Free Cash FlowTrailing 4 quarters | $-174.1M | $65.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-34.7M | $44.5M | ||
| Q3 25 | $-52.6M | $10.9M | ||
| Q2 25 | $-32.4M | $11.4M | ||
| Q1 25 | $-11.6M | $10.8M | ||
| Q4 24 | $-108.6M | $33.5M | ||
| Q3 24 | $-28.9M | $8.0M | ||
| Q2 24 | $-30.0M | $9.9M | ||
| Q1 24 | $-41.7M | $6.4M |
| Q4 25 | $-44.6M | $37.6M | ||
| Q3 25 | $-61.5M | $8.8M | ||
| Q2 25 | $-45.8M | $9.1M | ||
| Q1 25 | $-22.2M | $10.2M | ||
| Q4 24 | $-187.0M | $30.7M | ||
| Q3 24 | $-47.4M | $7.4M | ||
| Q2 24 | $-50.1M | $8.9M | ||
| Q1 24 | $-65.8M | $5.8M |
| Q4 25 | -99.4% | 144.5% | ||
| Q3 25 | -687.0% | 36.1% | ||
| Q2 25 | -267.9% | 38.8% | ||
| Q1 25 | -524.0% | 45.9% | ||
| Q4 24 | -3702.8% | 143.8% | ||
| Q3 24 | -728.4% | 37.6% | ||
| Q2 24 | -683.8% | 49.4% | ||
| Q1 24 | -661.5% | 33.6% |
| Q4 25 | 21.9% | 26.7% | ||
| Q3 25 | 99.7% | 8.9% | ||
| Q2 25 | 78.2% | 10.1% | ||
| Q1 25 | 251.1% | 3.0% | ||
| Q4 24 | 1552.7% | 13.0% | ||
| Q3 24 | 284.6% | 3.2% | ||
| Q2 24 | 274.6% | 5.4% | ||
| Q1 24 | 242.5% | 3.5% |
| Q4 25 | — | 9.59× | ||
| Q3 25 | — | 2.87× | ||
| Q2 25 | — | 3.16× | ||
| Q1 25 | — | 5.20× | ||
| Q4 24 | — | 7.44× | ||
| Q3 24 | — | 7.48× | ||
| Q2 24 | — | 12.10× | ||
| Q1 24 | — | 31.07× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.